NCT01423656View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102

PHASE1CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Atopic Dermatitis
Interventions
DRUG

LEO 29102

DRUG

Placebo

Placebo Comparator: LEO 29102 vehicle

Trial Locations (1)

LS2 9LH

Covance Clinical Research Unit Ltd., Leeds

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY